相关实验视频

Updated: Jun 6, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

在非小细胞肺癌患者接受新辅助免疫治疗后进行辅助治疗

Junfeng Zhao¹, Ying Li², Ruyue Li³

¹Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250000, China.

|December 2, 2024

概括

辅助免疫疗法与化疗相结合,在经过新辅助化疗和手术后,在非小细胞肺癌 (NSCLC) 患者中显著改善了无病生存率和整体生存率.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
胸部外科手术胸部外科手术

背景情况:

新辅助化疗和手术 (NICT) 是对非小细胞肺癌 (NSCLC) 的标准治疗方法.
在NICT和手术后辅助免疫治疗的作用仍然是一个研究领域.
优化辅助治疗策略对于改善NSCLC患者治疗结果至关重要.

研究的目的:

为了评估辅助免疫疗法与化疗相结合的疗效,与单独的化疗相比,NSCLC患者在NICT后和手术后的疗效.
在接受不同辅助治疗方案的患者中分析无疾病生存率 (DFS) 和整体生存率 (OS).

主要方法:

对209名接受新辅助化疗和手术 (NICT) 的非小细胞肺癌 (NSCLC) 患者的回顾性分析.
患者被分为两组:仅辅助化疗 (化疗组) 和辅助化疗加免疫治疗 (免疫+化疗组).
在两组之间比较了无疾病生存期 (DFS) 和总生存期 (OS).

主要成果:

与化疗组相比,免疫+化疗组的无疾病生存期 (DFS) 中位数显著更长 (未达到与26个月相比;HR:0.498,p=0.002).
与化疗组相比,免疫+化疗组的整体存活率 (OS) 显著改善 (HR:0.526,p=0.034).
在这两组中,均未达到中位 OS,这表明长期生存益处.

结论:

术后辅助化疗与免疫治疗相结合,在用NICT和手术治疗的NSCLC患者中,比单独的化疗更有效.
辅助免疫疗法代表了一种有前途的策略,以提高这种患者群体的生存结果.
需要进一步的前性研究来证实这些发现并建立最佳的治疗方案.

关键词:

卫生科学卫生科学医学专业医学专业医学医学医学医学医学治疗方法治疗方法

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...